Febuquik-80 mg Tablet

Composition of Febuquik-80 mg Tablet

Febuquik-80 mg Tablet contains Febuxostat 80 mg. It belongs to the Xanthine oxidase inhibitor class of medicines.

Uses of Febuquik-80 mg Tablet

Treatment of chronic hyperuricemia in patients with gout; helps prevent gout flares by lowering serum uric acid (not for treatment of acute gout attack).

Key benefits

• Lowers high uric acid levels
• Prevents recurrent gout attacks over time
• Helps dissolve urate crystal deposits
• Reduces risk of gout complications such as tophi

How Febuquik-80 mg Tablet works

Febuxostat is a xanthine oxidase inhibitor that reduces production of uric acid in the body. Lowering serum urate helps dissolve urate crystals and prevents new crystal deposition, reducing gout attacks over time.

How to take Febuquik-80 mg Tablet

Tablet for oral use. Take exactly as prescribed, usually once daily, with or without food; swallow with water. Therapy may be started with prophylaxis (e.g., NSAID/colchicine) to reduce flare risk; do not stop during a flare unless advised by doctor.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine can seriously suppress the bone marrow and damage the liver. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Febuquik-80 mg Tablet

Most side effects of Febuquik-80 mg are mild and settle as the body adjusts. Reported side effects include:

• Gout flare (especially at start)
• nausea
• diarrhea
• dizziness
• headache
• rash
• abnormal liver function tests (raised transaminases)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Febuquik-80 mg Tablet

Warnings and precautions

Not for relief of acute gout attack; gout flares may increase initially—continue medicine and use flare prophylaxis if advised. Use with caution in liver disease; monitor liver function periodically. Cardiovascular risk warning: use caution in patients with established cardiovascular disease; discuss risks/benefits with clinician. Avoid in patients taking azathioprine or mercaptopurine. Seek urgent care for signs of severe allergy/skin reactions (rash, blistering, facial swelling, breathing difficulty).

Do not take Febuquik-80 mg if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for people with an active serious infection, or with severe liver or bone-marrow disease. Several of these medicines must not be used in pregnancy.

Interactions with other medicines

Azathioprine, mercaptopurine (contraindicated/avoid due to severe toxicity), theophylline (use caution/monitor), didanosine (avoid/monitor uric acid), warfarin (generally no major interaction but monitor INR as clinically indicated)

How to store Febuquik-80 mg Tablet

Store below 25°C in a dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Febuquik-80 mg Tablet

Keep every monitoring blood test appointment. Carry a note of the medicine and its schedule, especially for weekly dosing.

Manufacturer and class

Manufacturer:

ERGOS LIFE SCIENCES

Therapeutic class:

Anti-gout (Uric acid lowering agent)

Drug class:

Xanthine oxidase inhibitor